First National Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-8,878
| Closed | -$295K | – | 333 |
|
|
2017
Q2 | $295K | Buy |
8,878
+555
| +7% | +$18.4K | 0.04% | 282 |
|
|
2017
Q1 | $267K | Sell |
8,323
-1,875
| -18% | -$60.2K | 0.03% | 280 |
|
|
2016
Q4 | $370K | Sell |
10,198
-1,191
| -10% | -$43.2K | 0.05% | 239 |
|
|
2016
Q3 | $524K | Sell |
11,389
-424
| -4% | -$19.5K | 0.08% | 197 |
|
|
2016
Q2 | $593K | Sell |
11,813
-657
| -5% | -$33K | 0.09% | 186 |
|
|
2016
Q1 | $667K | Buy |
12,470
+451
| +4% | +$24.1K | 0.1% | 173 |
|
|
2015
Q4 | $789K | Buy |
12,019
+1,320
| +12% | +$86.7K | 0.12% | 160 |
|
|
2015
Q3 | $604K | Buy |
10,699
+793
| +8% | +$44.8K | 0.1% | 185 |
|
|
2015
Q2 | $585K | Buy |
9,906
+305
| +3% | +$18K | 0.09% | 185 |
|
|
2015
Q1 | $598K | Buy |
9,601
+702
| +8% | +$43.7K | 0.1% | 173 |
|
|
2014
Q4 | $512K | Buy |
8,899
+680
| +8% | +$39.1K | 0.09% | 178 |
|
|
2014
Q3 | $442K | Sell |
8,219
-1,844
| -18% | -$99.2K | 0.08% | 184 |
|
|
2014
Q2 | $527K | Sell |
10,063
-2,739
| -21% | -$143K | 0.1% | 165 |
|
|
2014
Q1 | $676K | Sell |
12,802
-434
| -3% | -$22.9K | 0.12% | 143 |
|
|
2013
Q4 | $530K | Sell |
13,236
-2,286
| -15% | -$91.5K | 0.1% | 162 |
|
|
2013
Q3 | $587K | Sell |
15,522
-4,053
| -21% | -$153K | 0.12% | 151 |
|
|
2013
Q2 | $768K | Buy |
+19,575
| New | +$768K | 0.16% | 129 |
|